Real-World Data Or Studies Of Competitor Drugs Can Serve As Confirmatory Evidence For US FDA

Draft guidance describes seven types of confirmatory evidence that can be used with one adequate and well-controlled clinical study to demonstrate substantial evidence of effectiveness, including evidence from expanded access, real-world data, and studies of other drugs in the same class.